Abstract:Objectives Vitamin D deficiency has been associated with incident cardiovascular disease and cardiovascular mortality. Vitamin D receptor (VDR) activation through vitamin D or its analogues attenuates cardiomyocyte hypertrophy and cardiac dysfunction. Whether VDR status influences cardiomyocyte fate in the setting of myocardial ischaemia/reperfusion (MI/R) injury remains unknown. Our aim was to determine effects of cardiac VDR activation on MI/R injury. Methods The mice were randomly assigned to seven groups: sham, vehicle, paricalcitol (PC), In vivo VDR-siRNA + PC, In vivo VDR-siRNA + vehicle, In vivo control siRNA + PC, and In vivo control siRNA + vehicle. PC was administered through intraperitoneal injection at 20 ng/mouse/day for 2 days before MI/R. The last dose was administered at 15 min before reperfusion. The vehicle groups received vehicle injections using the same schedule. In vivo siRNA-mediated cardiac-specific VDR gene silencing was performed 48 h before MI/R. Following 30 minutes of ischaemia, the myocardium was reperfused. The mice were reperfused for 15 min (for protein phosphorylation levels), 3 h (for apoptosis, oxidation, nitration,and inflammation assays), 24 h (for cardiac function and infarct size assays), or 4 weeks (for left ventricular remodelling). The myocardial infarct size was determined using Evans blue-TTC double staining methods. Cardiac function was measured using an echocardiographic imaging system. DHE was used to detect ROS generation within the myocardium in situ . The nitrotyrosine levels were measured using immunostaining and ELISA.caspase-9, caspase-12, cleaved-caspase-8,gp91 phox , iNOS, phospho-JNK, and phospho-p38 MAPK were detected using western blot analysis. ANP, β-MHC, TNFα, IL1β, and IL6 expression were determined using real-time quantitative PCR. Results Low VDR expression was detected in the mouse heart, and MI/R upregulated VDR expression. The activation of VDR through PC reduced myocardial infarct size (23% vs. 44%, p phox and iNOS expression. Moreover, VDR activation suppressed the activation of proinflammatory kinases (p38 and JNK) and inflammatory cytokines [TNFα(-34%, p In vivo cardiac-specific VDR knockdown experiment demonstrated that intact VDR signalling was required for the anti-oxidative/anti-nitrative and anti-inflammatory effect of PC. Conclusions The results obtained in this study demonstrate VDR is a potent cardioprotective receptor against MI/R injury through the inhibition of oxidative/nitrative stress and inflammation and subsequent intrinsic and extrinsic caspase-mediated apoptosis. VDR represents a potential molecular therapeutic target for the treatment of ischaemic heart disease.

Novel Anti-Inflammatory Agent VCP979 Treatment Improves Cardiac Function in Post-Myocardial Infarction Diabetes Mice

Combined Treatment with Ultrasound-Targeted Microbubble Destruction Technique and NM-aFGF-loaded PEG-nanoliposomes Protects Against Diabetic Cardiomyopathy-Induced Oxidative Stress by Activating the AKT/GSK-3β1/Nrf-2 Pathway

Inhibition of JNK and P38 MAPK‐mediated Inflammation and Apoptosis by Ivabradine Improves Cardiac Function in Streptozotocin‐induced Diabetic Cardiomyopathy

Decreased expression of transient receptor potential vanilloid 1 impaires the postischemic recovery of diabetic mouse hearts.

Paeoniflorin Protects Diabetic Mice Against Myocardial Ischemic Injury Via the Transient Receptor Potential Vanilloid 1/calcitonin Gene-Related Peptide Pathway.

RTA 408 Ameliorates Diabetic Cardiomyopathy by Activating Nrf2 to Regulate Mitochondrial Fission and Fusion and Inhibiting NF-κB-mediated Inflammation.

Upregulation of P2X7 Exacerbates Myocardial Ischemia-Reperfusion Injury Through Enhancing Inflammation and Apoptosis in Diabetic Mice.

Activation of AMPK/p38/Nrf2 is involved in resveratrol alleviating myocardial ischemia-reperfusion injury in diabetic rats as an endogenous antioxidant stress feedback

Selective Inhibition Of Pkc Beta 2 Preserves Cardiac Function After Myocardial Infarction And Is Associated With Improved Angiogenesis Of Ischemic Myocardium In Diabetic Rats

Inhibition of High Glucose-Induced Inflammation and Fibrosis by a Novel Curcumin Derivative Prevents Renal and Heart Injury in Diabetic Mice

NAD + attenuates cardiac injury after myocardial infarction in diabetic mice through regulating alternative splicing of VEGF in macrophages

Inhibition Of Jnk Phosphorylation By A Novel Curcumin Analog Prevents High Glucose-Induced Inflammation And Apoptosis In Cardiomyocytes And The Development Of Diabetic Cardiomyopathy

Vildagliptin Attenuates Myocardial Dysfunction and Restores Autophagy via miR-21/SPRY1/ERK in Diabetic Mice Heart

The Novel Small-molecule Annexin-A1 Mimetic, Compound 17b, Elicits Vasoprotective Actions in Streptozotocin-induced Diabetic Mice

Activation Of Cardiac Vitamin D Receptor Attenuates Oxidative/Nitrative Stress And Protects Against Myocardial Ischaemia/Reperfusion Injury

Abstract 13045: Chronic Beta3-Adrenergic Receptor Antagonist Therapy Rescues Diabetic Cardiomyopathy in a Mouse Model With Type 2 Diabetes: Insights into Cellular Mechanism

ShengMai-San Attenuates Cardiac Remodeling in Diabetic Rats by Inhibiting NOX-Mediated Oxidative Stress

Abstract 339: Vasonatrin Peptide Attenuates Myocardial Ischemia/Reperfusion Injury in Diabetic Rats Through PKG-Mediated Inhibition of Endoplasmic Reticulum Stress

Astragaloside IV Ameliorates Myocardial Infarction Induced Apoptosis and Restores Cardiac Function

Taohuajing reduces oxidative stress and inflammation in diabetic cardiomyopathy through the sirtuin 1/nucleotide-binding oligomerization domain-like receptor protein 3 pathway

Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy